Literature DB >> 24581929

Presenting efficacy information in direct-to-consumer prescription drug advertisements.

Amie C O'Donoghue1, Helen W Sullivan2, Kathryn J Aikin2, Dhuly Chowdhury3, Rebecca R Moultrie3, Douglas J Rupert3.   

Abstract

OBJECTIVE: We evaluated whether presenting prescription drug efficacy information in direct-to-consumer (DTC) advertising helps individuals accurately report a drug's benefits and, if so, which numerical format is most helpful.
METHODS: We conducted a randomized, controlled study of individuals diagnosed with high cholesterol (n=2807) who viewed fictitious prescription drug print or television ads containing either no drug efficacy information or efficacy information in one of five numerical formats. We measured drug efficacy recall, drug perceptions and attitudes, behavioral intentions, and drug risk recall.
RESULTS: Individuals who viewed absolute frequency and/or percentage information more accurately reported drug efficacy than participants who viewed no efficacy information. Participants who viewed relative frequency information generally reported drug efficacy less accurately than participants who viewed other numerical formats.
CONCLUSION: Adding efficacy information to DTC ads-both in print and on television-may potentially increase an individual's knowledge of a drug's efficacy, which may improve patient-provider communication and promote more informed decisions. PRACTICE IMPLICATIONS: Providing quantitative efficacy information in a combination of formats (e.g., absolute frequency and percent) may help patients remember information and make decisions about prescription drugs. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Communication; DTC advertising; Quantitative information

Mesh:

Substances:

Year:  2013        PMID: 24581929     DOI: 10.1016/j.pec.2013.12.010

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  18 in total

1.  Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Kathryn J Aikin; Dhuly Chowdhury; Rebecca R Moultrie; Douglas J Rupert
Journal:  Patient Educ Couns       Date:  2015-12-22

2.  Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.

Authors:  Helen W Sullivan; Miriam Campbell
Journal:  J Health Commun       Date:  2015-06-29

3.  Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye Tracking Study.

Authors:  Helen Sullivan; Vanessa Boudewyns; Amie O'Donoghue; Sandra Marshall; Pamela A Williams
Journal:  J Public Policy Mark       Date:  2017-09-01

4.  Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.

Authors:  Amie C O'Donoghue; Helen W Sullivan; Pamela A Williams; Claudia Squire; Kevin R Betts; Jessica Fitts Willoughby; Sarah Parvanta
Journal:  J Health Commun       Date:  2016-07-14

5.  Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.

Authors:  Helen W Sullivan; Kathryn J Aikin; Jon Poehlman
Journal:  Health Commun       Date:  2017-11-10

6.  Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.

Authors:  Kathryn J Aikin; Helen W Sullivan; Amie C O'Donoghue; Kevin R Betts
Journal:  Health Mark Q       Date:  2016-10-19

7.  Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Douglas J Rupert; Jessica Fitts Willoughby; Kathryn J Aikin
Journal:  J Health Commun       Date:  2017-01-27

8.  Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Douglas J Rupert; Jessica Fitts Willoughby; Jacqueline B Amoozegar; Kathryn J Aikin
Journal:  J Health Commun       Date:  2016-11-02

9.  The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Molly Lynch; Mihaela Johnson; Christine Davis; Douglas J Rupert
Journal:  Med Decis Making       Date:  2019-10-04       Impact factor: 2.583

10.  Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.

Authors:  Matthew P Gray; Alvaro San-Juan-Rodriguez; Nemin Chen; Chester B Good; Inmaculada Hernandez
Journal:  Res Social Adm Pharm       Date:  2019-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.